A vascularized, immune-cell-containing heart-on-a-chip model reproduces inflammatory cardiac dysfunction, including cytokine elevation, impaired contractility, altered calcium handling, and circulating cell-free mitochondrial DNA changes. Endothelial extracellular vesicles rescued contractile and calcium-handling deficits in the model.
UC Berkeley is a comprehensive public research university of global scale, known for cross‑disciplinary inquiry and a high‑intensity research culture. Industry engages on campus through shared user facilities, project‑based collaborations, and embedded innovation spaces, with proximity to a U.S. Department of Energy national laboratory enabling joint programs and access to specialized instrumentation. Its Bay Area location connects partners to deep talent pipelines and a dense startup ecosystem, enabling rapid prototyping and iteration alongside regional suppliers and investors. Research is supported by competitive federal funding from agencies such as the National Science Foundation, Department of Energy, National Institutes of Health, and DARPA. A dedicated technology transfer office streamlines IP, sponsored research, material transfer agreements, and startup formation, complemented by accelerators and proof‑of‑concept resources.